Medical Equipment

Hormonal Intrauterine Devices (IUDs) Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

March 12, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Hormonal Intrauterine Devices (IUDs) Market Across 2026–2030?

The market size for hormonal intrauterine devices (IUDs) has seen rapid growth in recent years. It is forecast to increase from $2.87 billion in 2025 to $3.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.6%. This historical expansion can be attributed to a combination of factors including growing awareness of family planning options, the expansion of women’s reproductive healthcare programs, a rising preference for long-term contraception, the availability of hormone-based devices, and support from public health initiatives.

The market size for hormonal intrauterine devices (IUDs) is anticipated to experience rapid growth over the next few years. It is projected to expand to $4.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is attributed to the increasing demand for non-surgical contraceptive solutions, a rising focus on menstrual health management, the expansion of access in emerging markets, growing investments in women’s health technologies, and increasing innovation in hormone delivery systems. Significant trends expected in this period include the increasing adoption of low-dose hormonal IUDs, a rising demand for long-acting reversible contraceptives, a growing preference for frameless device designs, the expansion of therapeutic IUD applications, and an enhanced focus on patient comfort and safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Hormonal Intrauterine Devices (IUDs) Market?

The rising incidence of unplanned pregnancies is anticipated to stimulate the expansion of the hormonal intrauterine devices market moving ahead. Unwanted pregnancies are defined as those not intended or wished for at the point of conception. Such pregnancies can arise due to multiple factors, such as failed contraception, limited access to birth control methods, improper contraceptive use, or experiences of sexual violence. Restricted availability of potent contraception elevates the likelihood of unplanned pregnancies by diminishing individuals’ autonomy concerning their reproductive decisions. Hormonal IUDs demonstrate high efficacy in preventing pregnancy, boasting a failure rate of less than 1%. They offer prolonged protection, lasting 3 to 7 years, depending on the specific model, making them a trustworthy choice for individuals aiming to prevent unwanted pregnancies. As an illustration, in July 2025, data from the Society for Family Planning, a US-based professional organization, indicated that abortions climbed to 1.14 million in 2024, up from 1.05 million in 2023. Consequently, the uptick in unwanted pregnancies is propelling the expansion of the hormonal intrauterine devices market.

What Segmentation Levels Are Considered In The Hormonal Intrauterine Devices (IUDs) Market?

The hormonal intrauterine devices (iuds) market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

What Trends Are Projected To Affect The Hormonal Intrauterine Devices (IUDs) Market?

Leading companies within the hormonal intrauterine devices market are concentrating on developing advanced solutions, such as levonorgestrel intrauterine devices (IUDs), designed to alleviate menstrual bleeding and cramps. These levonorgestrel intrauterine devices (IUDs) are long-term birth control options inserted into the uterus that gradually release the hormone levonorgestrel to prevent pregnancy. For instance, in October 2024, Medicines360, a US-based nonprofit organization, introduced Avibela, a 52 mg levonorgestrel intrauterine device (IUD) in Zambia. This device serves two primary functions, offering up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive action derives from its ability to make cervical mucus denser, thereby stopping sperm from reaching the uterus. For heavy bleeding, it operates by thinning the uterine lining, which helps to decrease menstrual flow.

Which Leading Firms Are Contributing To The Growth Of The Hormonal Intrauterine Devices (IUDs) Market?

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

Read the full hormonal intrauterine devices (iuds) market report here:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Which Regions Are Projected To Dominate The Hormonal Intrauterine Devices (IUDs) Market In The Coming Years?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hormonal Intrauterine Devices (IUDs) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2026, By The Business Research Company

Contraceptive Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Gynecological Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/gynecological-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795